These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 206141)
21. Utility of TWEAK to assess neuropsychiatric disease activity in systemic lupus erhytematosus. Fragoso-Loyo H; Atisha-Fregoso Y; Nuñez-Alvarez CA; Llorente L Lupus; 2016 Apr; 25(4):364-9. PubMed ID: 26466614 [TBL] [Abstract][Full Text] [Related]
22. Urinary excretion of adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate in normal children and those with cystic fibrosis. Murad F; Moss WW; Johanson J; Selden RF J Clin Endocrinol Metab; 1975 Apr; 40(4):552-9. PubMed ID: 165210 [TBL] [Abstract][Full Text] [Related]
23. [cAMP and cGMP in the cerebrospinal fluid of patients with multiple sclerosis]. Maciejek Z; Jurkowski A; Chmielewski H Neurol Neurochir Pol; 1985; 19(6):471-4. PubMed ID: 3012386 [TBL] [Abstract][Full Text] [Related]
24. Serum and cerebrospinal fluid autoantibodies in patients with neuropsychiatric lupus erythematosus. Implications for diagnosis and pathogenesis. Fragoso-Loyo H; Cabiedes J; Orozco-Narváez A; Dávila-Maldonado L; Atisha-Fregoso Y; Diamond B; Llorente L; Sánchez-Guerrero J PLoS One; 2008 Oct; 3(10):e3347. PubMed ID: 18836530 [TBL] [Abstract][Full Text] [Related]
25. Elevated levels of soluble fractalkine in active systemic lupus erythematosus: potential involvement in neuropsychiatric manifestations. Yajima N; Kasama T; Isozaki T; Odai T; Matsunawa M; Negishi M; Ide H; Kameoka Y; Hirohata S; Adachi M Arthritis Rheum; 2005 Jun; 52(6):1670-5. PubMed ID: 15934075 [TBL] [Abstract][Full Text] [Related]
26. Relationship between the levels of cyclic cytidine 3':5'-monophosphate, cyclic guanosine 3':5'-monophosphate, and cyclic adenosine 3':5'-monophosphate in urines and leukocytes and the type of human leukemias. Scavennec J; Carcassonne Y; Gastaut JA; Blanc A; Cailla HL Cancer Res; 1981 Aug; 41(8):3222-7. PubMed ID: 6265079 [TBL] [Abstract][Full Text] [Related]
27. The fourth component of complement in the cerebrospinal fluid in systemic Lupus erythematosus. Hadler NM; Gerwin RD; Frank MM; Whitaker JN; Baker M; Decker JL Arthritis Rheum; 1973; 16(4):507-21. PubMed ID: 4722434 [No Abstract] [Full Text] [Related]
28. Intrathecal levels of matrix metalloproteinases in systemic lupus erythematosus with central nervous system engagement. Trysberg E; Blennow K; Zachrisson O; Tarkowski A Arthritis Res Ther; 2004; 6(6):R551-6. PubMed ID: 15535833 [TBL] [Abstract][Full Text] [Related]
30. Decreased levels of soluble amyloid beta-protein precursor and beta-amyloid protein in cerebrospinal fluid of patients with systemic lupus erythematosus. Trysberg E; Höglund K; Svenungsson E; Blennow K; Tarkowski A Arthritis Res Ther; 2004; 6(2):R129-36. PubMed ID: 15059276 [TBL] [Abstract][Full Text] [Related]
31. Anticardiolipin antibodies in serum and cerebrospinal fluid from patients with systemic lupus erythematosus. Martínez-Cordero E; Rivera García BE; Aguilar León DE J Investig Allergol Clin Immunol; 1997; 7(6):596-601. PubMed ID: 9491201 [TBL] [Abstract][Full Text] [Related]
32. [Concentrations of cyclic nucleotides in the cerebrospinal fluid of the aged patients with dementia (author's transl)]. Eto F; Okano K; Yoshikawa M; Hirai S Rinsho Shinkeigaku; 1979 Jan; 19(1):22-6. PubMed ID: 218760 [No Abstract] [Full Text] [Related]
33. Intrathecal cytokines in systemic lupus erythematosus with central nervous system involvement. Trysberg E; Carlsten H; Tarkowski A Lupus; 2000; 9(7):498-503. PubMed ID: 11035414 [TBL] [Abstract][Full Text] [Related]
34. Differences between central nervous system infection and neuropsychiatric systemic lupus erythematosus in patients with systemic lupus erythematosus. Fang H; Lan L; Qu Y; Zhang Q; Lv J J Int Med Res; 2018 Jan; 46(1):485-491. PubMed ID: 28823196 [TBL] [Abstract][Full Text] [Related]
35. CSF cyclic nucleotides and somatostatin in Parkinson's disease. Volicer L; Beal MF; Direnfeld LK; Marquis JK; Albert ML Neurology; 1986 Jan; 36(1):89-92. PubMed ID: 2867490 [TBL] [Abstract][Full Text] [Related]
36. Balance between inflammatory and regulatory cytokines in systemic lupus erythematosus. Yao Y; Wang JB; Xin MM; Li H; Liu B; Wang LL; Wang LQ; Zhao L Genet Mol Res; 2016 May; 15(2):. PubMed ID: 27323066 [TBL] [Abstract][Full Text] [Related]
37. Association of cerebrospinal fluid anti-ribosomal p protein antibodies with diffuse psychiatric/neuropsychological syndromes in systemic lupus erythematosus. Hirohata S; Arinuma Y; Takayama M; Yoshio T Arthritis Res Ther; 2007; 9(3):R44. PubMed ID: 17472755 [TBL] [Abstract][Full Text] [Related]
38. Cyclic guanosine monophosphate (cGMP), nitrite and nitrate in the cerebrospinal fluid in meningitis, multiple sclerosis and Guillain-Barré syndrome. Ikeda M; Sato I; Matsunaga T; Takahashi M; Yuasa T; Murota S Intern Med; 1995 Aug; 34(8):734-7. PubMed ID: 8563111 [TBL] [Abstract][Full Text] [Related]
39. [Cerebrospinal fluid monoamine metabolites and cyclic nucleotides in the patients with epilepsy (author's transl)]. Nagao T; Fujimoto A; Ohshimo T; Yamamoto M; Kugoh T; Akiyama K; Otsuki S No To Shinkei; 1979 Dec; 31(12):1225-31. PubMed ID: 93481 [No Abstract] [Full Text] [Related]
40. Elevated amniotic fluid nitric oxide metabolites and cyclic guanosine 3',5'-monophosphate in pregnant women with intraamniotic infection. Hsu CD; Aversa K; Meaddough E; Lee IS; Copel JA Am J Obstet Gynecol; 1997 Oct; 177(4):793-6. PubMed ID: 9369821 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]